The Evolving Telepsychiatry Landscape

June 13, 2022

The burgeoning telepsychiatry space faces rapidly evolving regulatory and competitive dynamics.  Marwood Group’s Mark Slomiany examines the market landscape and policy considerations in this behavioral health subsector as the public health emergency draws to an end.

View White Paper

The Resurgence of Independent Pharmacy

May 16, 2022

Independent community pharmacies, once written off, are benefiting from the tailwinds of a post-big box store era. Herein, Marwood’s Mark Slomiany elaborates on how the current landscape benefits nimble independent community pharmacies that not only achieve cost control but diversify their services.

View White Paper

Inflation May Accelerate Trends Reshaping the Healthcare Landscape

March 15, 2022

The recent spike in inflation has yet to fully percolate through the healthcare value chain. Marwood’s Mark Slomiany provides perspective on payor and provider measures and countermeasures likely to accelerate trends reshaping the industry.

View White Paper

2022 Global Pharmaceutical CDMO Outlook

February 14, 2022

In part two of Marwood’s CDMO outlook, Mark Slomiany and Tim Read explore the role CDMOs have played in supporting the pharmaceutical sector, as well as core areas inflecting growth, the evolving M&A landscape, and regulatory considerations.

View White Paper

2022 Global MedTech CDMO Outlook

February 4, 2022

Rapid innovation in the MedTech sector has original equipment manufacturers seeking CDMO partners that can provide operational efficiencies, specialized expertise, and enhanced quality to support device development and commercialization. Marwood reviews the core services and regulatory considerations that are driving changes in the sector.

View White Paper

Implications of Undercoding and Strategies to Avoid the Dangers

January 28, 2022

When it comes to mitigating compliance risk and audits, providers may actually draw greater risk to themselves by undercoding. Herein, Marwood reviews the risks of performing fraud and abuse by undercoding, the financial impact that it has on healthcare organizations, and actionable steps to mitigate future risk.

View White Paper

Pharmacy White Bagging: Growth And Countermeasures

November 24, 2021

“White bagging” is increasingly being utilized by insurers to control provider-administered drug spend. Herein, Marwood presents payor strategies and patient/provider pushback to its implementation.

View White Paper